NIH Partners with Israeli Startup to Generate Synthetic COVID-19 Data

ImageFlow/Shutterstock

The ultimate aim is to garner new, evidence-based insights to support the fight against the novel coronavirus.

Through a new partnership unveiled Tuesday, the National Institutes of Health will harness Israeli startup MDClone’s platform to generate computationally-derived synthetic data directly from clinical health data aggregated across the U.S., to underpin and advance research in the fight against COVID-19. 

The work is a notable piece of the NIH’s new National COVID Cohort Collaborative, or N3C, effort, through which the federal agency is offering approved users an opportunity to access “different levels” of COVID-19 patients’ clinical data—including a limited data set, a de-identified data set from that LDS and a synthetic data set—to quickly transform captured medical information into insights that can bolster research supporting the nation’s pandemic response. 

MDClone confirmed it’s providing the enabling technology for the synthetic workstream in N3C.

“Patient privacy is always a concern when managing healthcare data,” MDClone’s Chief Commercial Officer Josh Rubel told Nextgov via email Wednesday. “In the context of COVID-19, preserving privacy and allowing for research is of value to the NIH and its academic partners. MDClone has the unique ability to securely manage original patient data and convert it to synthetic data, which has the shape and structure of the original data but contains NO actual patient data.”

Information contained in COVID-19 patients’ electronic health records—when securely anonymized and combined in colossal volumes representing many individuals—could inform new and necessary insights needed to combat the ongoing health crisis. To produce and refine models and approaches to swiftly make use of those massive amounts of data, it must also be safely accessible across many sites. Through N3C, NIH aims to create a centralized data enclave that can be tapped by carefully selected experts to improve pandemic-driven research. Rubel explained that the strategic partnership and use of synthetic data will create a platform where critical information can be shared by many, “increasing both the depth and breadth of data that is accessible to researchers.”

“The end result of leveraging MDClone is access to a wider, more useful dataset without privacy risk,” he said, adding that by “preserving distributions and correlations inside the data, synthetic data makes it possible to conduct complex statistical analyses.”

For this work, the synthetic data will be used to drive new insights for priorities enveloping clinical best practices that promote better outcomes in mortality rates, predictive models that will forecast the disease's severity, potential responses to certain therapies, and more. 

Founded in 2016, MDClone is headquartered in Beer Sheba, Israel. On top of teaming with leading Israeli health care providers since its founding, the company also partnered with Canada this year, and in 2018, launched its first major project in the U.S. with the Washington University School of Medicine in St. Louis. Rubel noted that the tech startup was introduced to the NIH’s National Center for Advancing Translational Sciences, which is spearheading the N3C effort, through “standard professional networking based on MDClone’s experiences at two existing” NCATS partner sites—its first U.S. partner Washington University and Regenstrief Institute in Indiana. 

“The discussion started in February 2020 as part of market intelligence gathering around NIH efforts at creating usable nationwide research data sets,” Rubel explained. “As part of the focus created by the pandemic, the discussion shifted to COVID-19 research and we contracted in May of 2020.” 

The company’s platform was deployed and installed on the NIH network in early June, he noted, and the rest of NCATS’ multifaceted COVID-19 data environment will go live between June and July. From there, the initiative will be ongoing.

“NIH aggregates the data into the NCATS environment and it will be available in the MDClone platform,” Rubel said. “The process for data access and research includes offering academic researchers access to MDClone synthetic data through the MDClone application, existing NIH analytics tools, and/or a synthetic file portal.”  

Amid the pandemic, MDClone’s platform is being leveraged by others outside of NIH, as well. Israel’s Sheba Medical Center, for instance, has used it to track and trace real-time data to predict case severity, better inform treatment results, and explore trends associated with the reported cases of infection.

“Best case, MDClone will give the NIH and its academic network a research platform to quickly generate synthetic data sets for NIH and external research teams to find insights to understand COVID-19 behavior and explore best practices derived from real-world evidence,” Rubel said. “Additionally, the synthetic data will show that we can safely aggregate and make data broadly available, enabling scientists and healthcare professionals to have access to rich data to power discovery and solutions for a variety of healthcare challenges.”

X
This website uses cookies to enhance user experience and to analyze performance and traffic on our website. We also share information about your use of our site with our social media, advertising and analytics partners. Learn More / Do Not Sell My Personal Information
Accept Cookies
X
Cookie Preferences Cookie List

Do Not Sell My Personal Information

When you visit our website, we store cookies on your browser to collect information. The information collected might relate to you, your preferences or your device, and is mostly used to make the site work as you expect it to and to provide a more personalized web experience. However, you can choose not to allow certain types of cookies, which may impact your experience of the site and the services we are able to offer. Click on the different category headings to find out more and change our default settings according to your preference. You cannot opt-out of our First Party Strictly Necessary Cookies as they are deployed in order to ensure the proper functioning of our website (such as prompting the cookie banner and remembering your settings, to log into your account, to redirect you when you log out, etc.). For more information about the First and Third Party Cookies used please follow this link.

Allow All Cookies

Manage Consent Preferences

Strictly Necessary Cookies - Always Active

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Sale of Personal Data, Targeting & Social Media Cookies

Under the California Consumer Privacy Act, you have the right to opt-out of the sale of your personal information to third parties. These cookies collect information for analytics and to personalize your experience with targeted ads. You may exercise your right to opt out of the sale of personal information by using this toggle switch. If you opt out we will not be able to offer you personalised ads and will not hand over your personal information to any third parties. Additionally, you may contact our legal department for further clarification about your rights as a California consumer by using this Exercise My Rights link

If you have enabled privacy controls on your browser (such as a plugin), we have to take that as a valid request to opt-out. Therefore we would not be able to track your activity through the web. This may affect our ability to personalize ads according to your preferences.

Targeting cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.

Social media cookies are set by a range of social media services that we have added to the site to enable you to share our content with your friends and networks. They are capable of tracking your browser across other sites and building up a profile of your interests. This may impact the content and messages you see on other websites you visit. If you do not allow these cookies you may not be able to use or see these sharing tools.

If you want to opt out of all of our lead reports and lists, please submit a privacy request at our Do Not Sell page.

Save Settings
Cookie Preferences Cookie List

Cookie List

A cookie is a small piece of data (text file) that a website – when visited by a user – asks your browser to store on your device in order to remember information about you, such as your language preference or login information. Those cookies are set by us and called first-party cookies. We also use third-party cookies – which are cookies from a domain different than the domain of the website you are visiting – for our advertising and marketing efforts. More specifically, we use cookies and other tracking technologies for the following purposes:

Strictly Necessary Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Functional Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Performance Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Sale of Personal Data

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Social Media Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Targeting Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.